Pfizer Bids Farewell To Blue Pill With New Double Helix Logo
'Reveals DNA At Heart' Of Science-Focused Firm
Executive Summary
CEO Albert Bourla says the rebranding "marks the advent of the new Pfizer – the culmination of a bold, decade-long transformation from a scientific fast follower to a first-in-class scientific powerhouse."